[go: up one dir, main page]

ZA200206537B - Low PH high fatty acid vanishing cream. - Google Patents

Low PH high fatty acid vanishing cream. Download PDF

Info

Publication number
ZA200206537B
ZA200206537B ZA200206537A ZA200206537A ZA200206537B ZA 200206537 B ZA200206537 B ZA 200206537B ZA 200206537 A ZA200206537 A ZA 200206537A ZA 200206537 A ZA200206537 A ZA 200206537A ZA 200206537 B ZA200206537 B ZA 200206537B
Authority
ZA
South Africa
Prior art keywords
acid
fatty acid
composition according
weight
composition
Prior art date
Application number
ZA200206537A
Inventor
Rully Anjasmara Siswoyo
Dwiwahyu Haryo Suryo
Original Assignee
Unilever Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Plc filed Critical Unilever Plc
Publication of ZA200206537B publication Critical patent/ZA200206537B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Description

LOW pH HIGH FATTY ACID VANISHING CREAM
The present invention relates to stably suspended cosmetic vanishing creams of low pH.
Vanishing creams are popular around the world because they spread easily onto the skin giving a thin, semi-matte film which seems to disappear or “vanish”. They are also used to counteract shine which may arise from overactive sebaceous glands. Moreover, these creams counteract skin dryness to alleviate flaking, cracking and roughness.
The creams are usually formulated with high levels of stearic acid suspended in water by means of an emulsifying agent. Typically the emulsifying agent is a potassium or sodium soap formed by the in situ reaction of caustic potash or other alkali on a portion of the stearic acid.
Consequently, the formulations have a pH above 7, and usually substantially above, because of the presence of alkali. Humectants, such as glycerin, are normally also present in vanishing creams.
Emerging trends in skin care have required that vanishing cream formulations be adapted to incorporate skin benefit agents. For example, WO 99/37280 {Bartolone et al.) discloses vanishing creams which are formulated to include . alkali or alkaline earth metal salts of alpha-hydroxy carboxylic acids into order to achieve skin lightening . properties. The disclosure describes the new products as having a pH above 5. Care was taken 1n this prior art document not to incorporate acid versions of the alpha-
- 2 = hydroxy carboxylic acids into the formulations. %
Unfortunately, the beneficial properties of these skin benefit agents have not been realized in such formulations and thus, it was clear that further work was necessary in order to enhance the performance of vanishing creams.
In addition to alpha-hydroxy carboxylic acids it would also be desirable to incorporate other skin benefit agents. For example, U.S. Patent 5,482,710 (Slavtcheff et al.) discloses the use of alpha- and beta-hydroxycarboxylic acids in combination with salts of glycyrrhizinic acid, alpha- bisabolol and anti-microbial agents including triclosan.
Accordingly, the present invention aims to provide a vanishing cream having a relatively high level of fatty acid and a low pH to accommodate acidic skin benefit agents which enhance the performance of the formulation.
The present invention also aims to provide a cosmetic composition, particularly a vanishing cream of low pH, wherein skin benefit agents can be stably suspended in the composition.
These and other objects of the present invention will become more readily apparent from consideration of the following summary and detailed description.
A cosmetic composition is provided comprising: ] (1) from 5 to 50% by weight of a C12-Cpp fatty acid; (ii) from 0.1 to 20% by weight of a Cg-Cpy fatty acid substituted saccharide; wherein the composition has a pH from about 1 to about 6.5.
The applicants have surprisingly found that cosmetic vanishing creams can be stably formulated at a pH of about 6.5 or less by incorporation of a stabilizing amount of a
Cg-C22 fatty acid substituted saccharide. Vanishing creams of the present invention which have a high fatty acid content (over 5% of, for example, stearic acid) retain the traditional consumer benefits of such products even at low pH, namely good moisturization without greasiness/oiliness, ease of absorption, cool sensation and a matte finish.
Addition of acidic skin benefit agents results in improvements in the areas of rough/flaky skin, enhancement of skin cell renewal and reduction of pimples.
Consequently, a first essential component of the vanishing cream compositions of the present invention is a Ci12-Cyg fatty acid, preferably stearic acid. The fatty acid will be present in amounts ranging from 5 to 50%, preferably from 7 » to 40%, more preferably from 10 to 25%, optimally from 12 to 20% by weight of the composition. '
A second component of the vanishing cream compositions of the present invention is a Cg-Cpp fatty acid substituted . saccharide. Preferably, these components are Cg-Cp2 fatty acid substituted glucose materials, more preferably Cg-Cjy fatty acid and C1-C3 alkyl substituted glucose compounds.
Suitable Cg-Cpp fatty acid substituted saccharides include methyl glucose sesquistearate, ethyl glucose sesquistearate, propyl glucose sesquilstearate, methyl glucose sesquipalmitate, ethyl glucose sesquipalmitate, propyl glucose sesquipalmitate, methyl glucose sesquilaurate, ethyl glucose sesquilaurate, propyl glucose sesquilaurate, methyl glucose sesquibehenate, ethyl glucose sesquibehenate, propyl glucose sesquibehenate and any combinations thereof. Of these, the most preferred saccharide is methyl glucose sesquistearate (a CTFA and INCI nomenclature) available as
TEGO Care PS sold by Th. Goldschmidt AG. Amounts of the stabilizing agent may range from about 0.1 to about 20%, preferably from about 0.5 to about 10%, more preferably from about 1 to about 8%, optimally from about 2 to about 5% by weight of the composition.
An optional but advantageous substance which may be present in compositions of the present invention is an acidic skin benefit agent. Representative of this category are the alpha- and beta- hydroxy carboxylic acids. Illustrative of ¢ the beta-hydroxy carboxylic acids is salicylic acid. The alpha-hydroxy carboxylic acids are represented by formula I having the structure:
RI
: R—C —COOH 0
OH wherein R and rR may be the same or different and are selected from H, F, Cl, Br, alkyl, aralkyl or aryl groups which may be saturated or unsaturated, isomeric or nonisomeric, straight or branched chain, having 1 to 25 carbon atoms, or in a cyclic form having 5 or 6 ring members. In addition, R and rR: may be substituted with an
OH, CHO, COOH or alkoxy group having 1 to 9 carbon atoms.
The alpha-hydroxy acid exists as a free acid, and includes stereoisomers, and D, L, and DL forms thereof when R and R! are not identical.
Illustrative of this group of materials are: 2-hydroxyethanoic acid (glycolic acid); 2-hydroxypropanoic acid (lactic acid); 2-methyl 2- hydroxypropanoic acid (methyllactic acid); 2-hydroxybutanoic acid; 2-hydroxypentanoic acid; 2-hydroxyhexanoic acid; 2-hydroxyheptanoic acid; 2-hydroxyoctanoic acid; 2- hydroxynonanoic acid; 2-hydroxydecanoic acid; 2- hydroxyundecanoic acid; 2-hydroxydodecanoic acid (alpha- hydroxylauric acid); 2-hydroxytetradecanoic acid (alpha- hydroxymyristic acid); 2-hydroxyhexadecanoic acid (alpha- * hydroxypalmitic acid); 2-hydroxyoctadecanoic acid (alpha- hydroxystearic acid) ; 2-hydroxyeicosanoic acid (alpha- hydroxyarachidonic acid): 2-phenyl 2-hydroxyethanoic acid (mandelic acid}; 2,2-diphenyl 2-hydroxyethanoic acid
" woo1/70188 PCT/EP01/02344 (benzilic acid); 3-phenyl 2-hydroxypropanoic acid (phenyl : lactic acid); 2—phenyl, 2-methyl, 2-hydroxyethanoic acid (atrolactic acid); 2-(4’~-hydroxyphenyl) 2-hydroxyethanoic ) acid; 2-(4’ -chlorophenyl 2-hydroxyethanoic acid; 2-(3'~
S hydroxy-4’'-methoxyphenyl) 2-hydroxyethanoic acid; 2-(4" - hydroxy-3’ -methoxyphenyl)2-hydroxyethanoic acid; 37 -(2- hydroxyphényl) 2-hydroxypropanoic acid; 3-(4' -hydroxyphenyl) 2-hydroxypropanoic acid; and 2-(3',4’'-dihydroxyphenyl) 2- hydroxyethanoic acid.
Most preferred of this group of materials are glycolic acid, lactic acid, 2-hydroxyoctanoic acid or combinations thereof.
Levels of alpha-hydroxy alkanoic acids may range from about 0.1 to about 10%, preferably between about 0.2 and 1%, optimally between about 0.4 and 1% by weight of the composition.
In a particularly preferred embodiment, there will be present a mixture of both a beta-hydroxy carboxylic acid and an alpha-hydroxy carboxylic acid. For instance, the optimum combination is a mixture of salicylic acid and glycolic acid in a relative weight ratio from about 20:1 to about 1:20, preferably from about 10:1 to 1:1, optimally from about 3:1 to about 2:1.
Compositions of the present invention may also include a variety of anti-irritancy agents, particularly to counteract * any irritancy caused by the acidic skin benefit agents.
Suitable antli-irritancy agents include gluconolactone, borage seed oil, wild borage, dextran, alpha-bisabolol (extracted from chamomille), azulene (extracted from yarrow), resveratrol, petroselenic acid, and combinations ’ thereof. Each of these may be present at levels ranging from about 0.0001 to about 5%, preferably from about 0.001 to about 1%, optimally from about 0.01 to about 0.5% by weight of the composition.
Herbal extracts may also be included as components of the composition and are particularly effective for controlling the level of sebum/oil. Suitable extracts include dill, horseradish, oats, neem, beet, broccoli, tea, pumpkin, soybean, barley, walnut, flax, ginseng, poppy, avocado, pea, sesame, dandelion, wheat, nettle, cashew, pineapple, apple, asparagus, Brazil nut, chickpea, grapefruit, orange, cucumber, buckwheat, strawberry, ginko, tomato, blueberry, cowpea and grape extracts.
Other suitable herbal extracts include ivy horse chestnut, centella asiatica, rosmarinic acid, sericoside, ruscogenin, escin, escolin, betulinic acid, catechin and derivatives thereof. Each of these may be present in an amount ranging from about 0.00001 to about 2%, preferably between about 0.01 and about 0.5% by weight of the composition.
Anti-microbial agents may also be useful in compositions of the present invention. Typically the anti-microbial agents are selected from triclosan, tricarbanilide, tea tree oil, . farnesol, farnesol acetate, hexachlorophene, Cq4-C20 quaternary ammonium salts such as benzalconium chloride and } a variety of zinc or aluminum salts. Typically the zinc or aluminum salts are compounds such as zinc pyridinethione, zinc sulphate, zinc chloride, zinc phenolsulphonate,
© WO 0170188 PCT/EP01/02344 aluminum chloride, aluminum sulphate and aluminum : chlorhydrate. The anti-microbial agent may be present in amounts ranging from about 0.1 to about 5%, preferably from ) about 0.2 to about 1%, optimally about 0.3% by weight of the composition.
Compositions of the present invention ordinarily contain water as a carrier in amounts ranging from about 5 to about 95%, preferably from about 30 to about 90%, optimally from about 50 to about 85% by weight of the composition.
Emollient materials in the form of silicone oils or synthetic esters may be incorporated into the compositions of the present invention. These may be present in amounts ranging from about 0.1 to about 30%, preferably between about 1 and 20% by weight of the composition.
Silicone oils may be divided into the volatile and non- volatile variety. The term “volatile” as used herein refers to those materials which have a measurable vapor pressure at ambient temperature. Volatile silicone oils are preferably chosen from cyclic or linear polydimethylsiloxanes containing from about 3 to about 9, preferably from about 4 to about 5, silicon atoms.
Linear volatile silicone materials generally have viscosities less than about 5 centistokes at 25°C while cyclic materials typically have viscosities of less than . about 10 centistokes.
Nonvolatile silicone oils which are suitable as emollients . for the compositions of the present invention include polyalkyl siloxanes, polyalkylaryl siloxanes or polyether siloxane copolymers (e.g. dimethicone copolyol). Suitable non-volatile polyalkyl siloxanes include, for example, polydimethyl siloxanes with viscosities ranging from about 5 to about 100,000 centistokes at 25°C. Among the preferred non-volatile emollients which are useful in the present compositions are polydimethyl siloxanes having viscosities from about 10 to about 400 centistokes at 25°C.
Suitable ester emollients include: (1) alkenyl esters of fatty acids having 10 to 20 carbon atoms, such as methyl myristate, methyl stearate, oleyl myristate, oleyl stearate, or butyl oleate; (2) ether-esters such as fatty acid esters of ethoxylated fatty alcohols; (3) polyhydric alcohol esters, such as ethylene glycol mono and di-fatty acid esters, diethylene glycol mono- and di-fatty acid esters, polyethylene glycol (200-6000) mono- and di-fatty acid esters, propylene glycol mono- and di- fatty acid esters, polypropylene glycol 2000 monooleate, polypropylene glycol 2000 monostearate, ethoxylated propylene glycol monostearate, glyceryl mono- and di-fatty acid esters, polyglycerol poly-fatty esters, ethoxylated } glyceryl monostearate, 1,3-butylene glycol monostearate, 1,3-butylene glycol distearate, polyoxyethylene polyol fatty acid ester, sorbitan fatty acid esters, and polyoxyethylene ’ sorbitan fatty acid esters; (4) wax esters such as beeswax, spermaceti, myristyl myristate, stearyl stearate; (5) sterols esters, such as cholesterol fatty acid esters.
The preferred ester emollients are C;-C3 alkyl fatty esters such as methyl stearate, methyl myristate and methyl palmitate. Cg-Cz0 alkyl esters of fatty acids such as cetyl palmitate and myristyl myristate are also particularly preferred.
Humectants of the polyhydric alcohol-type may also be included in the compositions of the present invention. The humectant helps to increase the effectiveness of the emollient, reduces scaling, stimulates removal of built-up scale and generally improves skin feel. Typical polyhydric alcohols include glycerol, polyalkylene glycols and more preferably alkylene polyols and their derivatives, including propylene glycol, dipropylene glycol, polypropylene glycol, polyethylene glycol and derivatives thereof, sorbitol, hydroxypropyl sorbitol, isoprene glycol, hexylene glycol, 1,3-butylene glycol, 1,2,6-hexanetriol, ethoxylated glycerol, propoxylated glycerol and mixtures thereof. The amount of humectant may range anywhere from about 0.5 to about 30%, preferably between 1 and 15% by weight of the composition.
Thickeners/viscosifiers in amounts of up to about 5% by ) weight of the composition may also be included. The skilled person would appreciate that the precise amount of thickener required may vary depending upon the consistency and thickness of the composition desired. Suitable thickeners include xanthan gum, sodium carboxymethyl cellulose, hydroxyalkyl and alkyl celluloses (particularly hydroxypropyl cellulose), sclerotium gum and polyacrylamide dispersions in isoparaffin such as those sold by Seppic Inc. under the Sepigel® 305 trademark.
Preservatives may also desirably be incorporated into the cosmetic compositions of the present invention to protect against the growth of potentially harmful microorganisms.
Suitable traditional preservatives include alkyl esters of para-hydroxybenzoic acid. Other preservatives which have more recently come into use include hydantoin derivatives, propionate salts, and a variety of quaternary ammonium compounds. Cosmetic chemists are familiar with appropriate preservatives and routinely choose them to satisfy the preservative challenge test and to provide product stability. Particularly preferred preservatives are disodium EDTA, phenoxyethanol, methyl paraben, butyl paraben, propyl paraben, imidazolidinyl urea (commercially available as Germall 1157), sodium dehydroacetate and benzyl alcohol. The preservatives should be selected having regard for the use of the composition and possible incompatibilities between the preservatives and other . ingredients in the emulsion. The preservatives are preferably employed in amounts ranging from about 0.012% to about 2% by weight of the composition.
© WO 01/70188 PCT/EP01/02344
Advantageously, compositions of the present invention may contain glycyrrhizinic acid and salts thereof. These may be of the alpha or beta glycyrrhizinic variety. Particularly useful are the alkali metal and ammonium salts such as disodium and dipotassium glycyrrhizinate. Amounts of these substances may range from about 0.0001 to about 3%, preferably from about 0.01 to about 1.0%, optimally from about 0.1 to about 0.5% by weight of the composition.
Colorants and fragrances may also be included in the compositions of the present invention. These may be present in amounts ranging from about 0.05 to about 5%, preferably between about 0.1 and about 3% by weight of the composition.
Compositions of the present invention will have a pH ranging from about 1 to about 6.5, preferably from about 2 to about 6.0, more preferably from about 3 to about 5.5, optimally from about 3.5 to about 4.5.
Except in the operating and comparative examples, or where otherwise explicitly indicated, all numbers in this description indicating amounts of material are to be understood as modified by the word “about”.
The following examples will more fully illustrate the embodiments of this invention. All parts, percentages and proportions referred to herein and in the appended claims are by weight unless otherwise illustrated. "a
EXAMPLES 1-8
The following examples are illustrative of vanishing cream formulations according to the present invention.
Vanishing Cream [CoMpoNENTS |Exmwpl®
I FSR 2 TA 7 SU FT KA A 0 0
Lauric Acid ~~ [2.00 ]2.00[4.00 [4.00 [4.00 [1.00 ]1.00]10.00
Methyl Glucose 2.25 3.00 {2.00 2.00 2.25 3.25 1.00
Sesguistearate
Lactic Acid [1.00 [-- [3.00 [4.00 [7.00 [-- [1.00[--
Glycolic Acid | -- _j1.000-- J-- [-- "71.00 |-- [3.00
Cetyl Palmitate
Salicylic Acid
Methyl Paraben
Dipotassium 0.15 0.15] 0.15 0.15 0.15 0.15 0.15 0.15
Glycyrrhizinate
Silicone DC 200
Propyl Paraben
EXAMPLE 9
A series of stability tests were conducted to establish the performance of fatty acid saccharides as stabilizing agents for low pH vanishing creams. Table I provides formulations : of compositions which were comparatively tested.
© WO01/70188 PCT/EP01/02344
TABLE I
: ms Te Ip 15.00 [15.00 [15.00 [15.00
Methyl Glucose 2.25
Sesquistearate
Lauryl Polyglucose [-- ]1.69 12.25 [2.81
Cetyl Palmitate
Salicylic Acid
Methyl Stearate
Myristic Acid
Methyl Paraben
Dipotassium 0.15 0.15 0.15 0.15
Glycyrrhizzinate
Silicone DC 200-50
Propyl Paraben
Stability was determined in a 6 months storage stability test. Samples were stored for six months with temperatures alternating from 25°C (room temperature) to 6°C to 45°C and exposed to sunlight. Samples with satisfactory stability within the six month period may normally be expected to be stable for about 2-3 years in the marketplace.
Formulation A employing methyl glucose sesquistearate as a stabilizer provided a stable emulsion without any phase : separation. By contrast, replacement with an alkyl polyglucoside such as lauryl polyglucose at 75%, 100% and 125% of the methyl glucose sesquistearate levels (compare formulations B, C and D respectively) resulted in phase
© Wo o1/70188 PCT/EP01/02344 - 15 = instability with at least some water leaving the emulsion ) upon storage.
The foregoing description and examples illustrate selected embodiments of the present invention. In light thereof variations and modifications will be suggested to one skilled in the art, all of which are within the spirit and purview of this invention.
D

Claims (9)

oN WO 01770188 PCT/EP01/02344 I - 16 - . CLAIMS | oo
1. A cosmetic composition comprising: : : (i) from 5 to 50% by weight of a C32-Cpo fatty acid; (ii) from 0.1 to 20% by weight of methyl glucose sesquistearate; wherein the composition has a pH from about 1 to about 6.5.
2. A composition according to claim 1 wherein the C33-Czo fatty acid is stearic acid.
3. A composition according to claim 1 or claim 2 wherein the C;2-Coo fatty acid is present in an amount from about 10 to about 25% by weight.
4. A composition according to any one of the preceding claims further comprising an acidic skin henefit agent.
5. A composition according to claim 4 wherein the acidic skin benefit agent is selected from alpha-hydroxy carboxylic acids, beta-hydroxy carboxylic acids or mixtures thereof.
6. A composition according to claim 5 wherein the alpha- hydroxy carboxylic acids are selected from glycolic acid, lactic acid, 2-hydroxyoctanocic acid or combinations thereof.
’ 7. A composition according to claim 5 or claim 6 wherein , the beta-hydroxy carboxylic acid is salicylic acid. oo AMENDED SHEET - oo 2003 04-0 7 oo n \ FE
8. A composition according to any one of the preceding claims wherein the pH ranges from 2 to 6.0.
9. A composition according to any one of the preceding claims further comprising from about 0.0001 to about 3% by weight of glycyrrhizinic acid or a salt thereof. AMENDED SHEET 2003 -04- 07
ZA200206537A 2000-03-21 2002-08-15 Low PH high fatty acid vanishing cream. ZA200206537B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0006866A GB0006866D0 (en) 2000-03-21 2000-03-21 Low Ph high fatty acid vanishing cream

Publications (1)

Publication Number Publication Date
ZA200206537B true ZA200206537B (en) 2003-08-15

Family

ID=9888138

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200206537A ZA200206537B (en) 2000-03-21 2002-08-15 Low PH high fatty acid vanishing cream.

Country Status (4)

Country Link
AU (1) AU2001256180A1 (en)
GB (1) GB0006866D0 (en)
WO (1) WO2001070188A1 (en)
ZA (1) ZA200206537B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6979452B2 (en) * 2002-03-22 2005-12-27 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Low pH, high skin friction cosmetic creams
DE102006009850A1 (en) * 2006-03-01 2007-09-06 Beiersdorf Ag Use of glycyrrhetinic acid and / or glycyrrhizin for the preparation of cosmetic preparations for tanning the skin
DE102006009852A1 (en) * 2006-03-01 2007-09-06 Beiersdorf Ag Use of a cosmetic preparation containing glycyrrhizin and/or glycyrrhetinic acid and interface-active substances e.g. glucose derivative for strengthening the pigmentation of human skin
WO2013049956A1 (en) 2011-10-08 2013-04-11 Unilever Plc Composition for coloring skin and method for coloring skin
WO2018237218A1 (en) 2017-06-23 2018-12-27 The Procter & Gamble Company Composition and method for improving the appearance of skin
KR20210011964A (en) 2018-07-03 2021-02-02 더 프록터 앤드 갬블 캄파니 How to treat a skin condition
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
EP4157206A1 (en) 2020-06-01 2023-04-05 The Procter & Gamble Company Method of improving penetration of a vitamin b3 compound into skin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60255711A (en) * 1984-05-31 1985-12-17 Shiseido Co Ltd Pencil type cosmetic
DK318387D0 (en) * 1987-06-23 1987-06-23 Novo Industri As SURFACTIVE SUBSTANCE AND ITS APPLICATION
JPH03157349A (en) * 1989-11-14 1991-07-05 Lion Corp Emulsified composition
FR2710854B1 (en) * 1993-10-08 1995-12-01 Oreal Oil-in-water emulsion usable for obtaining a cream.
FR2736830B1 (en) * 1995-07-20 1997-10-10 Fabre Pierre Dermo Cosmetique COSMETIC COMPOSITION FOR BODY HYGIENE IN THE FORM OF AN OIL IN WATER EMULSION
JP3643844B2 (en) * 1995-12-27 2005-04-27 ライオン株式会社 Liquid composition for hair containing a crystalline compound
US5723645A (en) * 1996-09-05 1998-03-03 Pacific Corporation Method for preparing 3-aminopropane phosphoric acid
DE19733625A1 (en) * 1997-07-28 1999-02-04 Lancaster Group Gmbh Decorative cosmetic O / W emulsion
DE19905768A1 (en) * 1999-02-11 2000-08-17 Goldwell Gmbh Pre-emulsion for hair color production contains fatty alcohol ethoxylate, oleic acid, ethanediol and/or propanediol distearate and glycerol stearate and/or sugar fatty acid ester

Also Published As

Publication number Publication date
AU2001256180A1 (en) 2001-10-03
GB0006866D0 (en) 2000-05-10
WO2001070188A1 (en) 2001-09-27

Similar Documents

Publication Publication Date Title
EP0711143B1 (en) Cosmetic composition containing hydroxyacids
US5422112A (en) Thickened cosmetic compositions
US3953591A (en) Fatty acid, polysiloxane and water-soluble polymer containing skin conditioning emulsion
US5567427A (en) Emulsified, low ph cosmetic compositions having improved stability
US5425938A (en) Polyamino salts of alpha-hydroxyacids, alpha-ketoacids and related compounds
US6986895B2 (en) Thickened cosmetic compositions
US6159480A (en) Cosmetic makeup composition
ZA200108367B (en) Anti-Sebum skin care cosmetic compositions containing branched esters.
ZA200206537B (en) Low PH high fatty acid vanishing cream.
EP1424992B1 (en) Thickener system for cosmetic compositions
KR100585544B1 (en) Accelerating Cell Regeneration Composition
US6017548A (en) Skin care composition
US5807561A (en) Emulsifying system for a whitening cosmetic composition
ZA200206536B (en) Low PH high fatty acid vanishing cream.
US6074647A (en) Method of increasing skin cell renewal rate using acerola cherry fermentate
US5888521A (en) Method of increasing cell renewal rate
HK1018395B (en) Cell renewal rate compositions